Many of your patients struggle to maintain good glycemic control, despite their best intentions. Whether your patient has type 1 or type 2 diabetes, or they are being treated with an insulin injection regimen or pump therapy – they may benefit from CGM.
Who Can Benefit from CGM?
The Dexcom G4® PLATINUM Professional CGM System is practice-owned and gives you real-time feedback and insights about your patient’s glycemic control, which can inform therapeutic treatment recommendations. The System can be blinded when clinically necessary.
CGM can benefit all patients taking insulin – whether they’re taking multiple daily insulin injections or using a pump.
The Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System is the first CGM system approved as a replacement to fingersticks (“non-adjunctive use”). Now your patients can rely on the accuracy of the G5 Mobile to dose for a high and eat for a low—without the pain and hassle of a fingerstick.
*Fingersticks required for calibration, or if symptoms or expectations do not match readings, or when taking medications containing acetaminophen.
Dexcom will be your trusted partner in bringing CGM to your practice and patients. We assist with patient onboarding, including verification of insurance coverage, as well as provide clinician and patient training and education about CGM and the Dexcom products.